EchoIQ Ltd
ASX:EIQ
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.17
0.36
|
| Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
EchoIQ Ltd
Operating Income
EchoIQ Ltd
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
EchoIQ Ltd
ASX:EIQ
|
Operating Income
-AU$13.6m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-37%
|
CAGR 10-Years
N/A
|
|
|
Iress Ltd
ASX:IRE
|
Operating Income
AU$51.6m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-4%
|
|
|
WiseTech Global Ltd
ASX:WTC
|
Operating Income
AU$323.6m
|
CAGR 3-Years
25%
|
CAGR 5-Years
32%
|
CAGR 10-Years
N/A
|
|
|
TechnologyOne Ltd
ASX:TNE
|
Operating Income
AU$173.5m
|
CAGR 3-Years
15%
|
CAGR 5-Years
16%
|
CAGR 10-Years
15%
|
|
|
S
|
Siteminder Ltd
ASX:SDR
|
Operating Income
-AU$22m
|
CAGR 3-Years
20%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
|
Iris Energy Ltd
NASDAQ:IREN
|
Operating Income
$26.5m
|
CAGR 3-Years
133%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
EchoIQ Ltd
Glance View
EchoIQ Ltd. engages in the development, marketing and commercialization of software, products and services. The company is headquartered in Sydney, New South Wales. The company went IPO on 2010-12-17. The firm is engaged in the product development, marketing and commercialization of software products and services. The company provides cardiac diagnostics technology. ECHOiQ’s technology uses artificial intelligence (ai) assisted diagnostics to deliver real-world health solutions. Its screening program uses an AI backed system and access to cardiac big data that identifies patients at risk from aortic stenosis and other forms of structural heart disease. Its technology addresses aortic stenosis, heart failure, and mitral and tricuspid regurgitation. The firm also offers Prometheus that help health funds and insurers understand their providers. The company identifies providers showing signs or early indicators of unusual behaviors that might be related to fraud, claiming errors, or other patterns worthy of further investigation.
See Also
What is EchoIQ Ltd's Operating Income?
Operating Income
-13.6m
AUD
Based on the financial report for Jun 30, 2025, EchoIQ Ltd's Operating Income amounts to -13.6m AUD.
What is EchoIQ Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
-37%
Over the last year, the Operating Income growth was -83%. The average annual Operating Income growth rates for EchoIQ Ltd have been -28% over the past three years , -37% over the past five years .